For TKMS, Record Orders No Longer Guarantee Stock Gains as Market Demands Profits

German naval shipbuilder's shares drop 25% from October high even as backlog swells to ten times revenue; market awaits margin proof from Q3 results.

The stock of German naval shipbuilder TKMS has lost more than a quarter of its value since hitting a 52-week peak of €106.58 in October 2025, even as the company’s order book has swelled to an eye?popping €20.6 billion — roughly ten times annual revenue. On Monday, shares traded at €79.60, down 1.7% from Friday’s close, a modest move that nonetheless encapsulates a growing divide between operational momentum and investor sentiment.

Underpinning the operational story are two landmark developments. TKMS has clinched a €6.3 billion contract from the German navy for four MEKO A-200 DEU frigates, with an option for four more that could push the total value to nearly €9.9 billion. The first vessel is scheduled for delivery in 2029. The order came as the original F126 frigate program was scrapped in June 2026 after costs spiraled to an estimated €18 billion for just six ships. Meanwhile, CEO Oliver Burkhard has signaled that a roughly €8 billion submarine deal with India could be signed by the end of 2026. The potential contract would further inflate a backlog that already provides visibility far beyond typical industry horizons.

Solid financials underpin the narrative. In the first half of fiscal 2025/26, revenue rose 10% to €1.168 billion, while adjusted EBIT climbed 14% to €60 million. Investors will get the next update on August 12, 2026, when third?quarter results are released. By then, the India deal may have moved closer to signature, potentially offering a fresh catalyst.

Yet the market’s reaction tells a different story. The stock is up roughly 20% year?to?date, but the retreat from the October high reflects a broader re?evaluation of the entire defense sector. Alongside TKMS, Rheinmetall, Hensoldt and Renk have collectively shed nearly €60 billion in market value from their respective peaks. Morgan Stanley has downgraded European defense to “equal weight,” arguing that near?term momentum is insufficient to justify current valuations. Kepler analysts have been more pointed, labeling TKMS shares “too expensive.” The stock’s 30?day annualized volatility of 82.45% underscores the nervousness.

Technical indicators remain neutral. The relative strength index sits at 48.5 — neither overbought nor oversold — while the share price is barely 1.5% above its 200?day moving average. That equilibrium, however, masks a deeper shift. The automatic link between contract announcements and price jumps has broken. Orders alone no longer drive the stock; investors now want evidence that the record backlog will translate into sustained margin expansion and cash flow generation.

The structural tailwind from rising defense spending — reinforced by last year’s NATO summit in Ankara and a decade?long trend of higher military budgets — remains intact. But the market is no longer pricing that story blindly. For TKMS, the challenge is to prove that it can convert order?book growth into operational substance. The next earnings report will provide the first real test of whether the company can meet those heightened expectations.

With a market capitalization of €5.45 billion and a valuation that already assumes significant future success, the script has flipped: execution, not order headlines, will decide the stock’s next move.